BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

Australia Ovarian Cancer Study Group, EMBRACE, OCGN, PRostate cancer Asso Ciation group To Investigate Cancer Associated aLterations in the genome, GEMO Study Collaborators, HEBON

Research output: Contribution to journalArticle

51 Scopus citations

Fingerprint Dive into the research topics of 'BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences